Table 3.

Received therapy combinations and adverse drug reactions to those therapies.

Therapy combinations			Patients	Patients who had an ADR (relative frequency)
Intravenous mistletoe therapy alone			445	19 (4.3)
Intravenous mistletoe therapy	+	chemotherapy*	187	3 (1.6)
		chemotherapy* + immunotherapy	17	0
		surgery	13	0
		bisphosphonates	12	0
		chemotherapy* + radiation therapy	12	0
		immunotherapy	9	0
		hormone therapy	5	0
		radiation therapy	3	0
		bisphosphonates + hormone therapy	2	0
		signal transduction inhibitors	2	0
		chemotherapy* + hormone therapy + signal transduction inhibitors	1	0
		chemotherapy* + signal transduction inhibitors	1	0

*A total of 201 patients (55% of all patients that had chemotherapy and 42% of all i.v. mistletoe patients) received i.v. mistletoe and chemotherapy within close temporal proximity (very often on the same day). Of these patients, 63% also received corticosteroids as prechemotherapy medication (i.e., dexamethasone or prednisolone) at least once.